Go back to the public home page
Hello .
 United States 


  • News

    • International News

    • Education

    • Environment

    • Healthcare

    • Technology

      • Internet

    • Science

    • Social and Non-Profit

    • Local News

  • Politics
    and Policy

    • Government

    • Politics

    • Local Government

    • International Policy

  • Business
    and Economy

    • Economy

    • Finance

      • Financial Markets

    • Jobs and Labor

    • Company News

    • Industry News

      • Aerospace

      • Agriculture

      • Chemicals

      • Commodities

      • Construction and Engineering

      • Consumer Electronics

      • Defense

      • Energy

        • Nuclear Energy

        • Oil and Gas

        • Renewable Energy

      • Financial Services

        • Banking

        • Insurance

      • Fishing and Aquaculture

      • Manufacturing

      • Information Technology

      • Metals and Mining

      • Pharmaceuticals and Biotechnology

      • Real Estate

      • Professional and Business Services

        • Legal

      • Telecommunications

      • Tobacco

      • Retail

      • Transportation

        • Air Transportation

        • Maritime Transportation

        • Rail Transportation

        • Road Transportation

      • Utilities

      • Forestry and Wood Industry

  • Arts
    and Culture

    • Art

    • Books and Literature

    • Entertainment

      • Cinema

      • Media

        • Radio and Television

      • Music

  • Lifestyle
    and Leisure

    • Automotive

    • Home and Garden

    • Fashion and Luxury

      • Textile and Apparel

    • Food

    • Travel and Hospitality

    • Boating and Yachting


  • Sports

    • Baseball

    • Basketball

    • Boxing

    • Cricket

    • Cycling

    • Football (American)

    • Football (Australian)

    • Football (Soccer)

    • Golf

    • Hockey

    • Racing

    • Rugby

    • Sailing

    • Skiing and Winter Sports

    • Tennis

    • Volleyball

Results

  • Zyversa Therapeutics Inc.

    Failure to Satisfy Listing Rule (Form 8-K)

    -11h 17m

  • Zyversa Therapeutics Inc.

    ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes

    9/10

  • Zyversa Therapeutics Inc.

    ZyVersa Therapeutics Highlights Lipidomic Data in Alport Syndrome and DKD Reinforcing the Need for Drugs to Attenuate Damaging Renal Lipid Accumulation to Mitigate Disease Progression

    9/3

  • Zyversa Therapeutics Inc.

    ZyVersa Therapeutics Highlights Data Demonstrating a Critical Need for Therapies to Address Kidney Lipotoxicity to Alleviate Diabetic Kidney Disease (DKD) and Its Progression

    8/15

  • Zyversa Therapeutics Inc.

    ZyVersa Therapeutics Reports Second Quarter 2025 Financial Results and Highlights Key Near-term Value-building Milestones

    8/13

  • Zyversa Therapeutics Inc.

    Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q)

    8/13

  • Zyversa Therapeutics Inc.

    Notice of Effectiveness (Form EFFECT)

    8/7

  • Zyversa Therapeutics Inc.

    Amendment to Initial Registration Statement (Form S-1/A)

    8/1

  • Zyversa Therapeutics Inc.

    Material Event (Form 8-K)

    7/28

  • Zyversa Therapeutics Inc.

    Amendment to Initial Registration Statement (Form S-1/A)

    7/18

Copyright ©2006-2025 Public Technologies (PUBT) | Privacy Policy | Terms of Use | Contact